ENGERIX-B [Hepatitis B Vaccine (Recombinant)] is a sterile suspension of noninfectious hepatitis B virus surface antigen (HBsAg) for intramuscular administration. It contains purified surface antigen of the virus obtained by culturing genetically engineered Saccharomyces cerevisiae cells, which carry the surface antigen gene of the hepatitis B
HAVpur - Pharmacology: Provides active immunization against hepatitis A.
Indication: Active immunization of patients 12 mo of age and older against disease caused by hepatitis A virus.
VAQTA is indicated for active pre-exposure prophylaxis against disease caused by hepatitis A virus in persons 2 years of age and older.
HAVRIX (Hepatitis A Vaccine)
is a sterile suspension of inactivated virus for
administration. The virus (strain HM1
75) is propagated in MRC
5 human diploid
cells. After removal of the cell culture medium, the cells are lysed to
form a suspension. This